Nu Skin (NUS) AI Stock Analysis

• Market Cap: $548.93M
• Dividend Yield: 2.22%
• Average Volume (3M): 430.36K
• Price to Earnings (P/E): 5.5
• Beta (1Y): 1.09
• Revenue Growth: -11.79%
• EPS Growth: N/A
• Country: US
• Employees: 3,100
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 0.34
• Shares Outstanding: 49,497,715
• 10 Day Avg. Volume: 380,214
• 30 Day Avg. Volume: 430,357
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 0.00
• Enterprise Value/Revenue: 0.00
• Enterprise Value/Gross Profit: 0.00
• Enterprise Value/Ebitda: 0.00
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.99
• Revenue Forecast (FY): $1.48B

• Rating: 68 Neutral
• Price Target: $12.00 ▲(11.11% Upside)

Nu Skin's overall stock score reflects a promising outlook driven by strategic initiatives and strong performance in emerging markets. The attractive valuation and improved profitability are significant positives, though challenges in revenue growth and North American market performance remain concerns.

Positive Factors

Emerging Market Growth

Strong performance in Latin America indicates successful market penetration and potential for sustained growth in emerging regions.

Product Innovation

The launch of Prysm iO represents a strategic innovation, potentially driving future revenue and enhancing competitive positioning.

Improved Gross Margin

Consistent improvement in gross margin reflects effective cost management and product mix optimization, supporting long-term profitability.

Negative Factors

Revenue Decline

The decline in revenue year-over-year highlights ongoing challenges in maintaining sales momentum, which could affect long-term growth.

Challenges in North America

Persistent difficulties in North America suggest structural issues that may hinder market recovery and overall company performance.

Declining Free Cash Flow

A decline in free cash flow generation can limit financial flexibility and investment capacity, impacting future growth initiatives.

Nu Skin Business Overview & Revenue Model

Company Description

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

How the Company Makes Money

Nu Skin generates revenue primarily through the sale of its products to consumers via its network of independent distributors. The company employs a multi-level marketing (MLM) strategy, which allows distributors to earn commissions not only on their sales but also on the sales made by their recruits. This creates a tiered earning structure that incentivizes recruitment and sales. Key revenue streams include skincare and beauty products, dietary supplements, and personal care items, with a significant portion of sales originating from markets in Asia and North America. Partnerships with various health and wellness organizations, as well as investments in product innovation and technology, further enhance Nu Skin's market presence and contribute to its overall earnings.

Nu Skin Financial Statement Overview

Summary

Nu Skin is facing financial headwinds with declining revenues and profitability impacting both its income statement and balance sheet. While cash flow remains positive, the company needs to improve operational efficiency and profitability to strengthen its financial position. The balance sheet is moderately leveraged, providing some financial stability, but the company must focus on reversing its negative profitability trend.

Income Statement

Nu Skin has experienced declining revenue and profitability over the recent periods. The TTM revenue is down from previous years, and net income has turned negative. Gross profit margin remains relatively stable, but the net profit margin has deteriorated due to negative EBIT and EBITDA. The company needs to address its operational inefficiencies to return to profitability.

Balance Sheet

The balance sheet shows a moderate debt-to-equity ratio, indicating a balanced approach to leveraging. However, the decline in stockholders' equity and total assets is concerning. Return on equity has turned negative, reflecting poor profitability. The equity ratio remains stable, suggesting a decent level of financial stability despite recent challenges.

Cash Flow

Nu Skin's cash flow situation is relatively stable, with positive free cash flow and operating cash flow. However, the growth in free cash flow is limited, and the company has faced challenges in translating its cash flow into net income. Continued positive cash flow is a positive sign, but improvements in profitability are needed for long-term stability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.63B	1.73B	1.97B	2.23B	2.70B	2.58B
Gross Profit	1.09B	1.18B	1.36B	1.62B	2.02B	1.92B
EBITDA	196.71M	-78.83M	202.98M	231.85M	368.48M	331.56M
Net Income	100.83M	-146.59M	8.60M	104.78M	147.27M	191.35M
Balance Sheet
Total Assets	1.44B	1.47B	1.81B	1.82B	1.91B	1.96B
Cash, Cash Equivalents and Short-Term Investments	264.16M	197.99M	267.82M	278.51M	354.81M	423.90M
Total Debt	310.74M	478.23M	607.33M	520.52M	503.79M	500.38M
Total Liabilities	655.94M	817.46M	984.50M	923.67M	993.71M	1.06B
Stockholders Equity	787.75M	651.46M	821.97M	897.30M	912.77M	894.27M
Cash Flow
Free Cash Flow	58.62M	70.16M	60.15M	49.01M	72.97M	315.32M
Operating Cash Flow	93.40M	111.74M	118.64M	108.06M	141.58M	379.14M
Investing Cash Flow	170.17M	-37.96M	-134.50M	-67.08M	-88.73M	-79.43M
Financing Cash Flow	-229.43M	-133.18M	10.73M	-99.50M	-104.70M	-245.17M

Nu Skin Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 10.80
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NUS, the sentiment is Positive. The current price of 10.8 is above the 20-day moving average (MA) of 10.73, below the 50-day MA of 11.41, and above the 200-day MA of 8.69, indicating a neutral trend. The MACD of -0.13 indicates Negative momentum. The RSI at 47.22 is Neutral, neither overbought nor oversold. The STOCH value of 46.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NUS.

Nu Skin Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NUS	68 Neutral	$548.93M	5.54	13.68%	2.22%	-11.79%	―
ELF	65 Neutral	$6.69B	54.26	8.77%	―	13.80%	-25.02%
EPC	63 Neutral	$892.11M	14.18	4.12%	3.21%	-2.92%	-43.06%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
EL	61 Neutral	$32.83B	―	-20.73%	1.43%	-6.36%	-554.84%
COTY	45 Neutral	$3.35B	―	-9.96%	―	-5.68%	-358.36%
SKIN	43 Neutral	$175.02M	-4.90	-26.54%	―	-15.33%	75.52%

Nu Skin Corporate Events

Nu Skin Enterprises Reports Steady Q3 Earnings Amid Strategic Expansion

Nu Skin Enterprises Inc., a global leader in the beauty and wellness industry, operates through a dynamic affiliate platform offering personal care, nutrition, and anti-aging products across nearly 50 markets worldwide. The company, which also includes Rhyz Inc., is known for its innovative approach backed by over 40 years of scientific research.

Nu Skin’s Innovative Study on Skin Health: A Market Game-Changer?

Nu Skin Enterprises, in collaboration with ChinaNorm, is conducting a study titled Study on Carotenoid-Based Instrumental Index. The primary objective is to evaluate the effectiveness of a new biophotonic scanner, the Prysm device, in measuring skin carotenoid levels and analyzing their correlation with dietary and lifestyle factors. This study holds significance for understanding how lifestyle choices impact skin health.

Nu Skin Enterprises Surpasses Earnings Expectations Amid Challenges

Nu Skin Enterprises recently held its earnings call, revealing a blend of positive achievements and ongoing challenges. The company surpassed earnings expectations, demonstrating strong growth in Latin America and improvements in operational efficiency. However, it faces hurdles with declining revenues in North America and economic difficulties in China and South Korea. Despite these obstacles, the overall sentiment remains cautiously optimistic, driven by strategic plans and performance metrics.

Nu Skin Enterprises Reports Strong Q2 2025 Results

Nu Skin Enterprises Inc. is an integrated beauty and wellness company that operates globally, offering personal care, nutrition, and anti-aging products through a dynamic affiliate platform.